MARKET

BMEA

BMEA

Biomea Fusion, Inc.
NASDAQ

Real-time Quotes | Nasdaq Last Sale

18.85
-1.16
-5.78%
Opening 15:37 06/21 EDT
OPEN
20.20
PREV CLOSE
20.00
HIGH
20.24
LOW
18.71
VOLUME
83.13K
TURNOVER
--
52 WEEK HIGH
22.22
52 WEEK LOW
14.11
MARKET CAP
557.65M
P/E (TTM)
-101.8098
1D
5D
1M
3M
1Y
5Y
Biomea Fusion Posts Wider Q1 Loss
MT Newswires · 05/28 05:07
BRIEF-Biomea Fusion Reports First Quarter 2021 Financial Results
reuters.com · 05/27 21:58
Biomea Fusion EPS misses by $0.35
Biomea Fusion (BMEA): Q1 GAAP EPS of -$0.49 misses by $0.35.As of March 31, 2021, the Company had cash, cash equivalents, restricted cash, and investments of $57.5 million.Press Release
Seekingalpha · 05/27 20:51
Biomea Fusion Q1 EPS $(0.49) Down From $(0.05) YoY
Biomea Fusion (NASDAQ:BMEA) reported quarterly losses of $(0.49) per share. This is a 880 percent decrease over losses of $(0.05) per share from the same period last year.
Benzinga · 05/27 20:13
Biomea Fusion Reports First Quarter 2021 Financial Results and Business Highlights
-- Received $167 million in aggregate gross proceeds in April from initial public offering --
GlobeNewswire · 05/27 20:05
-- Earnings Flash (BMEA) BIOMEA FUSION Posts Q1 Loss $-0.49
MT Newswires · 05/27 16:16
Benzinga's Top Ratings Upgrades, Downgrades For May 11, 2021
 
Benzinga · 05/11 14:07
Jefferies Initiates Coverage On Biomea Fusion with Buy Rating, Announces Price Target of $26
Jefferies analyst Eun Yang initiates coverage on Biomea Fusion (NASDAQ:BMEA) with a Buy rating and announces Price Target of $26.
Benzinga · 05/11 11:46
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of BMEA. Analyze the recent business situations of Biomea Fusion, Inc. through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average BMEA stock price target is 26.50 with a high estimate of 27.00 and a low estimate of 26.00.
EPS
Institutional Holdings
Institutions: 0
Institutional Holdings: 0
% Owned: 0.00%
Shares Outstanding: 29.59M
TypeInstitutionsShares
Increased
0
0
New
0
0
Decreased
0
0
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+1.13%
Pharmaceuticals & Medical Research
+0.83%
Key Executives
President/Co-Founder
Ramses Erdtmann
Chief Executive Officer/Co-Founder
Thomas Butler
Senior Vice President - Finance/Primary Contact
Sunny Ryan
Chief Technology Officer
Heow Tan
Vice President - Operations
Naomi Cretcher
Independent Director
Sumita Ray
No Data
About BMEA
Biomea Fusion, Inc. is a preclinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The Company has built FUSION System discovery platform to advance a pipeline of irreversible small molecule product candidates. The Company's lead product candidate, BMF-219, is designed to be an orally bioavailable, potent and selective irreversible inhibitor of menin, an important transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers. The Company is developing BMF-219 for the treatment of liquid and solid tumors that are dependent on menin, including leukemias containing the mixed lineage leukemia (MLL) fusion protein. The Company is also advancing other preclinical irreversible programs for the treatment of select cancers.

Webull offers kinds of Biomea Fusion Inc stock information, including NASDAQ:BMEA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BMEA stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BMEA stock methods without spending real money on the virtual paper trading platform.